Showing results (581-590 of 5,475) with videos related to
Sort By:
Pageof 548
International Journal of Hematology|July 14, 2020
Changes of hematological and immunological parameters in COVID-19 patientsXiaohong Yuan, Wanling Huang, Bing Ye, et al.International Journal of Hematology|July 26, 2020
Successful management of hemodialysis-dependent refractory myeloma with modified daratumumab, bortezomib and dexamethasone regimenShinichi Mizuno, Chigusa Kitayama, Kenta Yamaguchi, et al.International Journal of Hematology|July 26, 2020
Risk of thromboembolism in patients with multiple myeloma treated with daratumumab: a systemic review and meta-analysisJiasheng Wang, Yeseong KimInternational Journal of Hematology|July 26, 2020
Living-donor liver transplantation providing an adequate chemotherapy for a pediatric patient with anaplastic large cell lymphoma complicated with liver failure due to the aggravation of biliary hepatopathy by secondary hemophagocytic lymphohistiocytosisKenichi Sakamoto, Tomoo Osumi, Satoshi Yoshimura, et al.International Journal of Hematology|July 3, 2020
Severe immune thrombocytopenic purpura in critical COVID-19Valérie Lévesque, Émilie Millaire, Daniel Corsilli, et al.International Journal of Hematology|June 30, 2020
Correction to: Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expressionNaoki Tamura, Hirona Maeda, Momoko Nishikori, et al.International Journal of Hematology|April 25, 2021
Circulatory miR-155 correlation with platelet and neutrophil recovery after autologous hematopoietic stem cell transplantation, a multivariate analysisMohammad Rafiee, Mehdi Allahbakhshian Farsani, Vahid Amiri, et al.International Journal of Hematology|April 22, 2021
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter studySabrina Giammarco, Simona Sica, Patrizia Chiusolo, et al.International Journal of Hematology|April 14, 2021
Management of primary immune thrombocytopenia in a real-world setting in Japan: eltrombopag versus corticosteroidsTze Fang Wong, Renata Majewska, Yoshiaki TomiyamaInternational Journal of Hematology|April 17, 2021
Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trialShinya Rai, Hiroaki Inoue, Hitoshi Hanamoto, et al.Pageof 548